The role of lymphadenectomy in patients undergoing radical cystectomy for bladder cancer

Current Oncology Reports

Volumn 9, Issue 3, 2007, Pages 213-221

  Stein, John P ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CANCER; CANCER GRADING; CANCER INCIDENCE; CANCER INVASION; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CYSTECTOMY; EVIDENCE BASED MEDICINE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; RISK ASSESSMENT; SURGICAL ANATOMY; SURGICAL TECHNIQUE; TREATMENT INDICATION;

CYSTECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; URINARY BLADDER NEOPLASMS;

EID: 34248585149     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-007-0024-1     Document Type: Review

References (41)

1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2005. CA: Cancer J Clin 2006, 56:106-130.
2. Prout G, Marshall VF: The prognosis with untreated bladder tumors. Cancer 1956, 9:551-558.
3. Stein JP: Indications for early cystectomy. Urology 2003, 62:591-595.
4. Stein JP, Lieskovsky G, Cote R, et al.: Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 2001, 19:666-675.
5. Leissner J, Ghoneim MA, Abol-Enein H, et al.: Extended radical LND in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 2004, 171:139-144.
6. Poulsen AL, Horn T, Steven K: Radical cystectomy; extending limits of pelvic LND improves survival for patients with bladder cancer confined to the bladder wall. J Urol 1998, 160:2015-2020, 1998.
7. Vieweg J, Gschwend JE, Herr HW, Fair WR: The impact of primary stage on survival in patients with lymph node positive bladder cancer. J Urol 1999, 161:72-76.
8. Leissner J, Hohenfellner R, Thuroff JW, Wolf HK: LND in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 2000, 85:817-823.
9. Vazina A, Dugi D, Shariat SF, et al.: Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol 2004, 171:1830-1834.
10. Abdel-Latif M, Abol-Enein H, El-Baz M, Ghoneim MA: Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis. J Urol 2004, 172:85-89.
11. Cheng CW, Ng CF, Chan CK, et al.: A fourteen-year review of radical cystectomy for transitional cell carcinoma demonstrating the usefulness of the concept of lymph node density. Int Braz J Urol 2006, 32:536-449.
12. Hautmann RE, Gschwend JE, de Petriconi RC, et al.: Cystectomy for transitional cell carcinoma of the bladder: results of a surgery-only series in the neobladder era. J Urol 2006, 176:486-492.
13. Madersbacher S, Hochreiter W, Burkhard F, et al.: Radical cystectomy for bladder cancer today- a homogenous series without neoadjuvant therapy. J Clin Oncol 2003, 21:690-686.
14. Montie JE: Against bladder sparing: surgery. J Urol 1999, 162:452-455.
15. Lebret T, Herve J-M, Lyonneau L, et al.: After cystectomy, is it justified to perform a bladder replacement for patients with lymph node positive bladder cancer? Eur Urol 2002, 42:344-349.
16. Stein JP, Quek ML, Skinner DG: Lymphadenectomy for invasive bladder cancer: I. Historical perspective and contemporary rationale. BJU Int 2006, 97:227-231.
17. Stein JP, Quek ML, Skinner DG: Lymphadenectomy for invasive bladder cancer. II. Technical aspects and prognostic factors. BJU Int 2006, 97:232-237.
18. Barth PJ, Gerharz EW, Ramaswamy A, et al.: The influence of lymph node counts on the detection of pelvic lymph node metastasis in prostate cancer. Pathol Res Pract 1999, 195:633-636.
19. Terrone C, Guercio S, DeLuca S, et al.: The number of lymph nodes examined and staging accuracy in renal cell carcinoma. BJU Int 2003, 91:37-40.
20. Smith JA, Whitmore WF Jr: Regional lymph node metastasis from bladder cancer. J Urol 1981, 126:591-593.
21. Bochner BH, Cho C, Herr HW, et al.: Prospective packaged LNDs with radical cystectomy: evaluation of node count variability and node mapping. J Urol 2004, 172:1286-1290.
22. Abol-Enein H, El-Baz M, Abd El-Hameed MA, et al.: Lymph node involvement in patients with bladder cancer treated with radical cystectomy: a patho-anatomical study - a single center experience. J Urol 2004, 172:11818-1821.
23. Stein JP, Cai J, Groshen S, Skinner DG: Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic LND: the concept of lymph node density. J Urol 2003, 170-35-41.
24. Bochner BH, Herr HW, Reuter VE: Impact of separate versus en bloc pelvic LND on the number of lymph nodes retrieved in cystectomy specimens. J Urol 2001, 166:2295-2296.
25. Stein Jp, Penson DF, Cai J, et al.: Radical cystectomy with an extended lymphadenectomy- evaluating separate package versus en bloc submission in node-positive bladder cancer. J Urol 2007, 177:876-881.
26. Grossman HB, Natale RB, Tangen CM, et al.: Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003, 349:859-866.
27. Herr HW, Faulkner JR, Grossman HB, et al.: Surgical factors influence bladder outcomes: a cooperative group report. J Clin Oncol 2004, 22:2781-2789.
28. Eastham JA, Kattan MW, Riedel E, et al.: Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol 2003, 170:2292-2295.
29. Konety BR, Joslyn SA, O'Donnell MA: Extent of pelvic LND and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the surveillance, epidemiology and end results program data bade. J Urol 2003, 169:945-50.
30. Herr H, Lee C, Chang S, Lerner S, For the Bladder Cancer Collaborative Group: Standardization of radical cystectomy and pelvic LND for bladder cancer; a collaborative group report. J Urol 2004, 171:1823-1828.
31. Brossner C, Pycha A, Toth A, et al.: Does extended LND increase the morbidity of radical cystectomy? BJU Int 2004, 93:64-66.
32. Queck MI, Stein JP, Clark PE, et al.: Microscopic and gross extravesical extension in pathologic staging of bladder cancer. J Urol. 2004, 171:640-645.
33. Lerner SP, Skinner DG, Lieskovsky G, et al.: The rationale for en bloc pelvic LND for bladder cancer patients with nodal metastases: long-term results. J Urol 1993, 149:758-764.
34. Vieweg J, Gschwend JE, Herr HW, Fair WR: Pelvic LND can be curative in patients with node positive bladder cancer, J Urol 1999, 161:449-454.
35. Herr HW: Superiority of ratio based lymph node staging for bladder cancer. J Urol 2003, 169:943-945.
36. Frank I, Cheville JC, Blute ML, et al.: Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy. Cancer 2003, 97:2425-2431.
37. Knap MM, Lundbeck F, Overgaard J: The role of pelvic LND as a predictive and prognostic factor in bladder cancer. Eur J Cancer 2003, 39:604-613.
38. Vieweg J, Whitmore WF Jr, Herr HW, et al.: The role of pelvic LND and radical cystectomy for lymph node positive bladder cancer. Cancer 1994, 73:3020-3028.
39. Herr HW, Bochner BH, Dalbagni G, et al.: Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 2002, 167:1295-1298.
40. Herr HW: Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology 2003, 61:105-108.
41. Honma I, Masumori N, Sato E, et al.: Removal of more lymph nodes may provide better outcome, as well as more accurate pathologic findings, in patients with bladder cancer-analysis of role of pelvic LND. Urology 2006, 68: 543-548.